Under normal conditions, antioxidants protect hepatocytes from oxidative stress–induced apoptosis, whereas in pathological states such as fibrosis or cancer, they can modulate signaling pathways (e.g., p53, NF-κB) to promote apoptosis and limit disease progression [55]. This evidence concerns the gene TP53 and cancer.